UNSPSC 85721372: Supplement left metatarsal-phalangeal joint with synthetic substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left metatarsal-phalangeal joint with synthetic substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SUN0JZ

UNSPSC 85721372 Supplement left metatarsal-phalangeal joint with synthetic substitute, open approach is a Commodity code that shows no relevant recent activity in state and local procurement. The six recent opportunities posted under this code between July and September 2026 involve occupational health medical surveillance, independent disability medical evaluations, surgical benefit carve-out programs, emergency and specialty healthcare for youth in detention, pharmacy benefit management, and temporary clinical staffing — none of which align with orthopedic joint supplementation or surgical implant procurement. The mismatch between the code's nominal scope (a specific surgical procedure on foot joints using synthetic materials) and the medical services and staffing opportunities tagged to it suggests this code either has been applied to records in error by issuing bodies or does not reflect genuine state and local procurement activity for the surgical implant product itself.

State and local procurement under this code, if it occurs at all, does not surface in recent RFP, RFQ, IFB, or ITB notices. No geographic clustering, issuing-body pattern, or representative orthopedic implant solicitation emerges from the available records. Firms evaluating pursuit under this code should verify directly with state health departments, public hospital systems, and large integrated health networks whether joint-supplementation implant procurement is actually tagged to this UNSPSC number in practice, as current market signals do not support active demand.